Mark Sada is a Cardiology physician. OpenAlex indexes 9 publications with 337 citations (h-index 6).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1941 Johnson Ave
Ste 101
San Luis Obispo, CA 934014154
Telephone
805-782-8844Provider last certified this registry record 14 Oct 2024.
Industry payments
17 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Abbott LaboratoriesProgram year202517 payments
- Biosense Webster, Inc.Program year202518 payments
- Medtronic, Inc.Program year20257 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
78.8%Statin19.8%Atorvastatin Calcium75%Rosuvastatin Calcium22%Simvastatin4%Part D≥288 patientsBeta blocker16.8%Metoprolol Succinate58%Carvedilol21%Metoprolol Tartrate19%Labetalol Hcl1%Atenolol1%Part D<11 patients+ 15 more classes in this area
Blood & clotting
16.2%Factor Xa inhibitor10.2%Eliquis87%Xarelto13%Part D≥144 patientsP2Y12 inhibitor5.5%Clopidogrel69%Brilinta21%Prasugrel Hcl10%Part D≥72 patients+ 2 more classes in this area
Metabolism & gastrointestinal
4.2%Proton pump inhibitor1.9%Pantoprazole Sodium91%Omeprazole9%Part D<11 patientsSGLT2 inhibitor1.8%Jardiance100%Part D≥30 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Primary angioplasty and selection bias inpatients presenting late (>12 h) after onset of chest pain and ST elevation myocardial infarction
Journal of the American College of Cardiology
2002 - Influence of Payor on Use of Invasive Cardiac Procedures and Patient Outcome After Myocardial Infarction in the United States
Journal of the American College of Cardiology
1998 - TACHY: An expert system for the management of supraventricular tachycardia in the elderly
American Heart Journal
1998 - Benefit of primary angioplasty in patients presenting late with ST segment elevation and acute myocardial infarction
Journal of the American College of Cardiology
1998
Similar KOLs
Other experts from the same institution or the same specialty.
Gregory Y.H. Lip
Medical University of Białystok
Mika Kivimäki
University of Helsinki
Salim Yusuf
Population Health Research Institute
Victoria Delgado
Institute of Molecular Bioimaging and Physiology
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”